2B7J:F:F-iShares MSCI World SRI UCITS ETF USD (Dist) (EUR)

ETF | Others |

Last Closing

USD 8.47

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.24 (-0.46%)

USD 128.40B
SXR8:F iShares Core S&P 500 UCITS ETF..

-2.20 (-0.39%)

USD 114.04B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.41 (-0.71%)

USD 108.41B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.07 (-0.46%)

USD 52.77B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 52.44B
VUSA:F Vanguard Funds Public Limited ..

-0.36 (-0.37%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

+0.03 (+0.44%)

USD 46.87B
0ZC:F Zscaler Inc

+3.55 (+1.37%)

USD 37.92B
BSND:F Danone SA

-0.10 (-0.68%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

-0.04 (-0.03%)

USD 24.77B

ETFs Containing 2B7J:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.15% 32% F 45% F
Dividend Return -4.54% 17% F 1% F
Total Return -9.70% 16% F 34% F
Trailing 12 Months  
Capital Gain 5.93% 56% F 61% D-
Dividend Return -3.69% 13% F 1% F
Total Return 2.23% 36% F 48% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.52% 58% F 58% F
Dividend Return 6.43% 55% F 50% F
Total Return -0.09% 4% F N/A F
Risk Return Profile  
Volatility (Standard Deviation) 9.71% 68% D+ 92% A
Risk Adjusted Return 66.22% 67% D+ 76% C+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.